SEC Tracker
Get the app
BHC · XBRL financial data

Bausch Health Companies financial statements, every quarter

The same tables from 12 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

Download Excel Download CSV
How these numbers work
  • Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
  • Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
  • * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
  • 0 means a filing states zero; a dash (—) means no filing states that number.
  • “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
  • Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
  • Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
  • Shares outstanding come from each filing's cover page, as of the date printed there.
  • Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

CSV

Fiscal quarters (BHC's year ends in late December)

In millions of dollarsDec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026Sep 30, 2026
Revenue from contracts with customers2,408*2,1532,4032,5102,559*2,2592,5302,6812,796*2,5242,8522,941
Selling, general and administrative766*794832850820*867894795882*861907834
Other operating income (expense)(28)*0(20)(225)(2)*(15)18(80)(65)*(32)(26)(11)
Operating income (loss)362*281389318558*276444619474*(950)740983
Interest income7*9879*1113159*101113
Interest expense363*355350346337*330465412397*402396398
Other income (expense)(28)*0(20)(225)(2)*———year only———
Income tax expense (benefit)40*84971111*391237159*7788151
Net income (loss)(39)*(64)10(85)93*(58)148179(112)*(1,423)258436
Earnings per share, basic USD per share(0.11)*(0.17)0.03(0.23)0.25*(0.16)0.400.48(0.30)*(3.82)0.691.16
Earnings per share, diluted USD per share(0.11)*(0.17)0.03(0.23)0.25*(0.16)0.400.48(0.29)*(3.82)0.681.15
Weighted average shares, basic millions of shares366*367368368369*370371371372*373375376
Weighted average shares, diluted millions of shares364*367370368367*370373376382*373378381

Balance sheet

CSV

Fiscal quarters (BHC's year ends in late December)

In millions of dollarsDec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026Sep 30, 2026
Cash and cash equivalents9477335957191,1811,1341,7271,3081,3091,2991,8252,485
Inventory1,5441,6361,6121,6551,5951,6131,6551,5981,6291,6011,6021,591
Prepaid and other current assets1,092957874852838890906894852874819796
Total current assets5,5965,3965,2115,3515,7745,7326,5146,2496,1575,9786,5227,408
Property and equipment, net1,7071,7131,7381,7891,7801,8821,9942,0262,074———
Right-of-use asset185———211———215———
Goodwill11,18311,16011,12711,17111,08711,15311,29811,28711,2719,8079,7939,767
Total assets27,35026,91326,49526,54026,52326,42127,26626,82426,36624,49824,79425,484
Accounts payable719642579667656620627616600593593517
Accrued liabilities3,1333,2253,3383,3863,4223,3543,4693,5983,3443,0373,0703,349
Current portion of long-term debt4505384524532,674282879579225889866866
Total current liabilities4,3024,4054,3694,5066,7524,2564,9754,7934,1804,5304,5444,749
Long-term debt21,93821,53621,20821,05418,94221,22820,85920,46320,59219,87519,87519,771
Lease liability, non-current148———165———167———
Total liabilities27,43227,08726,72226,78226,84526,66127,11926,46825,98925,58025,59625,825
Accumulated deficit(9,778)(9,842)(9,832)(9,917)(9,824)(9,882)(9,734)(9,555)(9,667)(11,090)(10,832)(10,396)
Total stockholders' equity(1,022)(1,115)(1,175)(1,174)(1,279)(1,183)(764)(565)(554)(2,059)(1,771)(1,328)
Total liabilities and equity27,35026,91326,49526,54026,52326,42127,26626,82426,36624,49824,79425,484
Common shares outstanding (cover page) millions of shares365367367368368370370371371373374374

Cash flows

CSV

Fiscal quarters (BHC's year ends in late December)

In millions of dollarsDec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026Sep 30, 2026
Net income (loss)(39)*(64)10(85)93*(58)148179(112)*(1,423)258436
Stock-based compensation29*3336*38*43*4346*43*84*5254*52*
Net cash from operating activities390*211380*405*601*211289*405*495*230670*814*
Purchases of property and equipment98*8278*71*106*11599*91*92*10977*66*
Net cash from investing activities(148)*(73)(79)*(102)*(200)*(130)(100)*(83)*(282)*(139)(93)*(83)*
Proceeds from long-term debt146*7580*0*506*5010,372*(1)*133*2,80284*44*
Repayments of long-term debt203*390495*164*411*1689,967*704*352*2,857112*113*
Net cash from financing activities(79)*(340)(424)*(189)*85*(146)358*(719)*(235)*(100)(49)*(80)*
Net change in cash182*(207)(132)*127*451*(44)586*(403)*(15)*(13)526*650*

Compare with peers

SIC 2834 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen
  • SIC 2834 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
  • Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
  • Runway shows only for companies burning cash with under $10B of public float.
  • * marks a quarter worked out from the filing totals: for a 10-K, the year less the first three quarters; for a 10-Q, the year-to-date total less the earlier one.
  • A cell reading “not reported” means the filings give no figure for that quarter alone.
CompanyCash ($M)Revenue, quarter ($M)Operating cash flow, quarter ($M)Shares outstandingRunwayQuarter
Bausch Health Companies2,4852,941814*374.3M— 10-QSep 30, 2026
Recursion Pharmaceuticals55019(77)*622.8M6.2 quarters 10-QSep 30, 2026
Agios Pharmaceuticals10045(57)*59.7M10.8 quarters 10-QJun 30, 2026
Vericel1257716*51.2M— 10-QJun 30, 2026
Biocryst Pharmaceuticals155not reported104*255.5M— 10-QJun 30, 2026
Indivior Pharmaceuticals30535697*118.0M— 10-QSep 30, 2026
Apellis Pharmaceuticals405268(61)128.0M6.6 quarters 10-QMar 31, 2026
Acadia Pharmaceuticals385308101*172.3M— 10-QJun 30, 2026
Amicus Therapeutics214185*16*314.0M— 10-KDec 31, 2025

Not investment advice. Not affiliated with the U.S. SEC.